Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MERCK SHARP DOHME

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 64
  • 0 comments

FDA approve CLESROVIMAB-CFOR

Comment Full text

RUBICON

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 53
  • 0 comments

FDA approve LABETALOL HYDROCHLORIDE

Comment Full text

GENENTECH INC

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 52
  • 0 comments

FDA approve GLOFITAMAB-GXBM

Comment Full text

CELLTRION INC

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 63
  • 0 comments

FDA approve RITUXIMAB-ABBS

Comment Full text

ASTELLAS

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 61
  • 0 comments

FDA approve ZOLBETUXIMAB-CLZB

Comment Full text

AMNEAL

  • FDA Approval
  • June 11, 2025, 08:51 UTC
  • 57
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text

LANNETT CO INC

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 51
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 55
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 45
  • 0 comments

FDA approve SILDENAFIL CITRATE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • June 11, 2025, 08:48 UTC
  • 59
  • 0 comments

FDA approve PEMBROLIZUMAB

Comment Full text
  • Previous
  • 164
  • 165
  • 166
  • 167
  • 168
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351009)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192756)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin